Skip to Content
Merck
  • The molecular basis of selective DNA binding by the BRG1 AT-hook and bromodomain.

The molecular basis of selective DNA binding by the BRG1 AT-hook and bromodomain.

Biochimica et biophysica acta. Gene regulatory mechanisms (2020-05-08)
Julio C Sanchez, Liyang Zhang, Stefania Evoli, Nicholas J Schnicker, Maria Nunez-Hernandez, Liping Yu, Jeff Wereszczynski, Miles A Pufall, Catherine A Musselman
ABSTRACT

The ATP-dependent BAF chromatin remodeling complex plays a critical role in gene regulation by modulating chromatin architecture, and is frequently mutated in cancer. Indeed, subunits of the BAF complex are found to be mutated in >20% of human tumors. The mechanism by which BAF properly navigates chromatin is not fully understood, but is thought to involve a multivalent network of histone and DNA contacts. We previously identified a composite domain in the BRG1 ATPase subunit that is capable of associating with both histones and DNA in a multivalent manner. Mapping the DNA binding pocket revealed that it contains several cancer mutations. Here, we utilize SELEX-seq to investigate the DNA specificity of this composite domain and NMR spectroscopy and molecular modelling to determine the structural basis of DNA binding. Finally, we demonstrate that cancer mutations in this domain alter the mode of DNA association.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Pipette filler for calibrated microcapillary pipettes, dispenses up to 100 μL
Sigma-Aldrich
Ficoll® PM 400, Type 400